MACDONALD, R., LOCH,DAVIS, CARA, R.,BURTON, KEVIN,WINCHESTER, GARY,STELLA, ANGELA, R.
申请号：
SG11201407266P
公开号：
SG11201407266PA
申请日:
2013.05.09
申请国别(地区):
SG
年份:
2014
代理人:
摘要：
The described invention provides a biodegradable, biocompatible delivery system of flowable sustained release microparticulate composition of a substantially pure crystalline form of a bioactive agent such as, for example, nimodipine, a process of preparing a therapeutic form of a substantially pure crystalline form of the bioactive agent and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury.
